MCDERMOTT+

Lobbying for PATIENTS FOR AFFORDABLE DRUGS NOW · non-partisan national patient organization fighting to lower drug prices

Filing 3rd Quarter - Termination

3rd Quarter (July 1 - Sep 30) 2026 · District of Columbia · House · Senate · $20,000.00 income · posted Aug 28, 2026

Lobbying activity 3

Health Issues

Issues related to prescription drug competition and pricing.

Consumer Issues/Safety/Products

Issues related to prescription drug competition and pricing.

Medicare/Medicaid

Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.